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Summary
Background: It would be useful to have a clinical test that increases the suspicion of white coat hypertension (WCH) 
during the medical consultation.
Objective: To evaluate the Slow Breathing Test (SBT) when differentiating hypertension from WCH.
Methods:  101 hypertensive patients selected at triage had their medication withdrawn for 2-3 weeks. The blood pressure 
(BP) was measured before and after the SBT at two consultations at the office. The test consisted in breathing for 1 
minute at the frequency of one respiratory cycle every 10 seconds. Two diagnostic criteria were compared: 1 – decrease 
in diastolic BP ≥10% in at least one visit or 2- decrease in BP to normal levels (<140/90 mm Hg) in at least one visit. 
The ambulatory blood pressure monitoring (ABPM) was performed while blinded to the clinical measurements. 
Results: 71 women and 30 men, with a mean age of 51+10 years, with mean pre and post-test BP of 152+17/ 99+11 
and 140+18/ 91+11 mm Hg were assessed. Nine patients had normal clinical and ambulatory measurements. Of the 
92 patients, 28 (30%) were classified as having WCH; 15 had a positive test for Criterion 1 and 21 for the Criterion 
2. Among 64 (70%) hypertensive individuals, 14 tested positive for Criterion 1 and 12 for Criterion 2. Sensitivity and 
specificity (95% CI): 0.54 (0.36-0.71) and 0.78 (0.67-0.87) for Criterion 1; 0.75 (0.57-0.87) and 0.81 (0.70-0.89) for 
Criterion 2.
Conclusions: The SBT showed an increase in the clinical suspicion of WCH in two visits when using the BP normalization 
criterion. This finding suggests that the test can help in the optimization of ABPM requests for suspected cases. (Arq 
Bras Cardiol 2008;91(4):243-249)
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Introduction
White coat hypertension (WCH), the most commonly 
used designation of isolated office hypertension, is defined 
as the presence of persistently elevated blood pressure (BP) 
in the medical environment and normal readings outside 
of it1. It affects 15 to 30% of the presumable hypertensive 
individuals2. This condition can lead to an unnecessary 
drug treatment, with consequences for patients and health 
systems3. On the other hand, WCH must be considered 
a pre-hypertensive state4,5 and not an innocent state6,7, 
which needs a more intense follow-up. Diagnosis of WCH 
requires preferentially, the use of ambulatory blood pressure 
monitoring (ABPM)8. However, since the lack of clinical 
features is characteristic of WCH, this factor restricts the 
requisition of ABPM as a diagnostic tool9. 
Slow breathing, at a frequency of 0.1 Hz (6 respiratory 
cycles per minute, 1 cycle every 10 seconds), showed to 
be effective in increasing blood oxygenation, exercise 
tolerance and baroreflex sensitivity10,11 and decreasing BP in 
hypertensive individuals11. It is presumed that this frequency 
promotes the synchronization between breathing and 
innate cardiovascular rhythms (Mayer waves, a 10-second 
rhythm in humans), with a consequent modulation of the 
central and peripheral (baroreflex)12 autonomic activities. 
At a frequency of 5 cycles per minute, slow breathing 
produced a small difference in the decrease of diastolic 
BP between hypertensive individuals and those with WCH, 
when applied on a single visit13.
The aim of the present study was to improve the use of the 
Slow Breathing Test (SBT), which could increase the suspicion 
of WCH at the office and consequently, optimize the requests 
for ABPM for the suspected cases.
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Methods
Study design and patients
In this cross-sectional accuracy study, 101 patients 
referred to the Service of Hypertensive Cardiology of 
the Federal University of Sao Paulo (Unifesp), between 
March 2003 and March 2005, were assessed through an 
initial triage. The assessment consisted of a structured 
questionnaire and interpretation of laboratory and 
electrocardiogram results, which are part of the routine 
assessment of the Service. 
The questionnaire included: when was hypertension 
diagnosed, anti-hypertensive medication used (name 
and dose), other medications being used, smoking and 
drinking habits, other diseases, hospital admissions 
(including hypertensive emergency/urgency treatment). 
At triage, inclusion criteria were: adult patients (age ≥ 
18 years) with systolic BP (SBP) ≥140 and <180 mmHg 
or diastolic BP (DBP) ≥90 and <110 mmHg or those 
using anti-hypertensive medication and BP <180/110 
mmHg. Exclusion criteria were: patients with a history of 
treatment for hypertensive crises of any origin, secondary 
hypertension, diabetes mellitus, atrial fibrillation, unstable 
angina or angina of recent onset, valvulopathies with 
functional class > 1, moderate to severe chronic obstructive 
pulmonary disease, serum creatinine ≥1.5 mg/dl, Body 
Mass Index ≥35, presence of Sokolow-Lyon index (SV 1, + 
R V 5/V 6 ≥35 mm) at the ECG and alcoholism.  All patients 
gave their free and informed consent to participate in the 
study and the study protocol was approved by the Ethics 
Committee in Research of Unifesp. 
Slow breathing test and BP measurements
The selected patients were assessed 2 to 3 weeks after the 
withdrawal of anti-hypertensive medication14. The auscultatory 
measurement of BP (Korotkoff sounds I and V) was obtained 
through a mercury sphygmomanometer (Wan Med, São 
Paulo, Brazil) with a  2 mm graduation and cuffs that were 
adequate to the circumference of the arm. With the patients 
in the sitting position, the BP was measured in both arms and 
the arm with the highest BP was chosen. After two minutes, a 
new measurement in the same arm was performed. In case of 
differences in DBP > 5 mmHg, the procedure was repeated 
until a measurement with a lower difference was obtained. 
With the cuff positioned on the chosen arm, the patient was 
submitted to the slow breathing test (SBT), which consisted in 
inducing slow breathing for a minute at the frequency of 0.1 
Hz (one respiratory cycle every 10 seconds). The patient was 
instructed by the doctor to simulate the respiratory pattern 
based on an analog clock placed on the table. Immediately 
after that, a single BP measurement was carried out in the 
previously chosen arm. The pulse frequency was estimated 
by a 30-second counting, by the radial pulse, immediately 
after the pre- and post-test measurements. 
Subsequently, a monitor was installed to perform the 24-
hour ABPM (Dyna-MAPA, Cardios Sistemas, São Paulo, Brazil; 
equivalent to Mobil-O-Graph, I.E.M., Stolberg, Germany) 
with an appropriate cuff placed on the non-dominant arm 
and programmed to measure BP every 15 minutes (while 
awake) and 30 minutes (during sleep). The sleeping and 
awake times were established individually and checked with 
the diary entries. On the following day, after the monitor 
removal, the same previously described procedures were 
performed to measure BP before and after the SBT at a new 
visit. The interpretation of the ABPM results was carried out 
while blinded to the clinical measurements and according to 
the Brazilian guidelines15. Patients with at least 50 readings 
while awake were included in the analysis. 
Reproducibility
Interobserver reproducibility was verified based on the 
measurements obtained separately by a second physician who 
tested 20 patients twice, immediately after the consultations 
carried out by the first observer. Each doctor performed the 
assessment in isolation and no observer was allowed during 
the procedure to prevent the patient’s BP elevation16.  All the 
clinical measurements were obtained in the morning between 
11 AM and 12 PM. 
Diagnostic criteria 
We considered as WCH the existence of office measurements 
≥140 mmHg (SBP) or ≥90 mm Hg (DBP) at the two visits 
(also at the triage if the patient was not taking medication) 
and ABPM mean while awake <135 mm Hg (SBP) and <85 
mm Hg (DBP).
Two criteria were compared as a positive response to the 
SBT for the diagnosis of WCH. Criterion 1: decrease in DBP 
≥10% in at least one of the visits. Criterion 2: decrease in 
BP to normal levels, i.e., SBP <140 and DBP <90mmHg in 
at least one of the two visits. 
Statistical analysis
Considering a mean prevalence of 20% of WCH, alpha 
error of 5% and statistical power of the sample of 90%, 
we estimated as necessary to have 92 individuals with a 
presumable diagnosis of sustained hypertension. The results 
were expressed as means and standard deviations (SD). The 
paired Student’s t test and the Chi-square test were used to 
analyze the results. The performance of the SBT was evaluated 
by the determination of sensitivity, specificity, predictive values 
and likelihood ratio, with the respective 95% confidence 
intervals. To evaluate the interobserver reproducibility of the 
SBT, Kappa test was used. The statistical analyses were carried 
out with the programs Microsoft Excel and Confidence 
Interval Analysis, version 2.
Figure 1 summarizes the present study method:
Results
Some characteristics of the sample
The sample consisted of 71 women and 30 men, with 
a mean age of 51±10 years. Of the 101 patients, 57 
were Caucasians, 40 were Black and 4 were Asians. Ten 
patients were aged ≥ 65 years (7 women). Ninety-four 
patients used anti-hypertensive medication. Of these, 17 
used monotherapy, 74 used 2 medications and 3 patients 
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Figure 1 -  Diagnostic Algorithm of the Study; BP - blood pressure; TOD – target-organ damage; BMI - body mass index; ↓DBP - decrease in diastolic blood pressure; 
↓BP - decrease in blood pressure; ABPM - ambulatory blood pressure monitoring; WCH - white coat hypertension. 
used 3 medications (the latter used suboptimal doses). The 
drugs used belonged to the following categories: thiazide 
diuretics, betablockers, dihydropiridinic calcium channel 
blockers and angiotensin-converting enzyme inhibitors 
(ACEI).
Classification after the ABPM 
The pre- and post-test BP means were 152±17 / 99±11 
and 140±18 / 91±11 mm Hg, respectively. 
Nine patients presented normal clinical and ambulatory 
measurements after medication withdrawal. Of the remaining 
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Table 1 – Blood pressure responses (systolic/diastolic ± SD), 
respective percentage variations and significance at the clinical 
visits before and after the SBT and means of ABPM while awake 
(±SD)
HT (n=64) WCH (n=28)
BP1 pre 158 ± 18 / 101 ± 10 150 ± 13 / 92 ± 8
BP1 post 149 ± 17 / 97 ± 10 140 ± 12 / 87 ± 8
∆%(p) -6 * / -4 ** -7 * / -6 **
BP2 pre 154 ± 16 / 99 ± 10 146 ± 11 / 89 ± 9
BP2 post 142 ± 15 / 95 ± 10 132 ± 12 / 84 ± 9
∆%(p) -8 * / -4 ** -11 * / -6 **
ABPM 
(awake) 144± 10 / 91± 8 125± 6 / 77± 6
SBT - slow breathing test,   BP1, BP2 - BP means at the 1st and 2nd visits, 
pre- and post-SBT; ∆% (p) - percentage variation (p value); * = p<0.0001 
** = p<0.003
Table 2 – Patient distribution according to criteria 1 and 2.
WCH (n=28) HT (n=64)
Criterion 1: 
↓DBP≥10% 15 14
↓DBP<10% 13  50
Criterion 2:  ↓
BP<140/90 21 12
↓BP≥140/90 7 52
WCH - white coat hypertension; HT - hypertension; ↓DBP≥10% - decrease 
in diastolic BP ≥10% after the SBT in at least one of the two visits; ↓
DBP<10% - decrease in diastolic BP <10% after the SBT in both visits; ↓
BP<140/90 - BP decrease to a value <140/90 mm Hg after SBT in at least 
one of the two visits; ↓BP≥140/90 - BP decrease to a value ≥140/90 mm 
Hg after SBT in both visits. 
Slow breathing test performance
Table 5 summarizes the SBT performance for the two criteria. 
The sensitivity, specificity, predictive values, likelihood ratios 
and Kappa test for the analysis of interobserver reproducibility 
were calculated, with the respective confidence intervals 
(Wilson’s method).
Graph 1 shows the improvement in the performance of 
the SBT in terms of sensitivity, specificity and predictive values 
when the same cut-off value used in the clinical diagnosis 
(140/90 mm Hg for criterion 2) was applied.
Discussion
The SBT showed sensitivity of 75% and specificity of 
81% for the BP normalization criterion in the identification 
of WCH in two visits, when non-medicated hypertensive 
patients, with no target-organ damages and no important 
comorbidities were assessed. The positive likelihood ratio 
obtained by the test points to an up to four-fold increase 
in the chance of WCH. These results suggest that this is 
a simple, easy-to-apply test by the clinician at the office, 
which allows a considerable increase in the suspicion of 
this diagnosis. 
We performed a concordance analysis between two 
observers and found a Kappa test of 0.42 for the BP 
normalization criterion, completely acceptable for a clinical 
maneuver in a situation that presents great variability. 
The variations in BP represent a problem for the diagnosis 
and control of hypertension. The spontaneous pre-test 
decrease in BP between visits 1 and 2 (Table 1) confirms the 
necessity of having at least 2 visits after triage to attenuate 
the patient’s alert reaction to a medical environment18,19. 
Through this procedure, we found 9 normotensive patients 
(9% of the initial sample) all of them previously taking 
antihypertensive drugs. On the other hand, WCH seems 
to be a conditioned response that does not disappear with 
time20 and of which diagnosis depends on the level of the 
suspicion by the physician. 
92, 28 (30%) were classified as having WCH (35% of the women 
and 20% of the men) and 64 (70%) as hypertensive (HT).
Table 1 shows the BP means (±SD) at the first and second 
visits before and after the SBT was applied and the ABPM 
means (±SD) while awake in relation to the WCH and HT 
groups. As expected, the pre-test means in the WCH group 
were lower than those in the HT group. 
A spontaneous pre-test decrease in BP was observed 
between visits 1 and 2 in both groups. A significant decrease 
in systolic and diastolic BP after the test in both groups was 
also observed.
The highest decrease was observed at visit 2 in the WCH 
group; the lowest decrease was observed at visit 1 in the HT 
group. There was no significant difference between the pre- 
and post-test means of pulse frequency for both groups.
For the WCH group and according to criterion 1, 8 patients 
were identified at visit 1 and 7 at visit 2; 4 patients responded 
positively to the SBT at the two visits. Regarding criterion 2, 
12 patients were identified at visit 1 and 9 at visit 2; 9 patients 
responded positively to the SBT at both visits. 
Positive responses to both criteria were observed in 12 
patients and 5 were not identified by either of the criteria. 
 Tables 3 and 4 show the responses to the SBT (positive 
or negative) by criteria 1 and 2, according to the stages of 
hypertension defined by the V Brazilian Guidelines17 and by 
the measurements registered at visit 2. In the WCH group, 
25 individuals had clinical measurements compatible with 
stage 1 arterial hypertension; the other 3, with stage 2. In 
the HT group, 35 individuals had clinical measurements 
compatible with stage 1 arterial hypertension, 24 with stage 
2 and 5 with stage 3. 
For the patients with BP compatible with stage 1, there was 
a significant difference between HT and WCH in response to 
the test for the criterion 2 (p<0.003), but not for criterion 
1 (p<0.26).
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Table 3 – Response to SBT according to the stages of hypertension (clinical measurements after consultation 2) using criterion 1
WCH+ (n=15) WCH–(n=13) HT+ (n=15) HT– (n=49) Total (n=92)
Stage 1 13 12 12 23 60
Stages 2 and 3   2 1 3 26 32
SBT - slow breathing test, WCH: white coat hypertension, HT - hypertensive; criterion 1: decrease in DBP ≥10% after SBT in at least one of the two visits, +: positive 
response to the test; -: negative response to the test; tage 1: BP entre 140 and 159 (systolic) and 90 and 99 mm Hg (diastolic); Stages 2 and 3: BP ≥160/100 mmHg
Table 4 – Response to SBT according to the stages of hypertension (clinical measurements after visit 2) using criterion 2
WCH+ (n=21) WCH– (n=7) HT+ (n=12) HT– (n=52) Total (n=92)
Stage 1 19 6 12 23  60
Stages 2 and 3 2 1 0 29 32
SBT - slow breathing test, WCH - white coat hypertension, HT- hypertensive; criterion 2: decrease in DBP to < 140/90 mm Hg after SBT in at least one of the two 
visits; + - positive response to the test; -: negative response to the test; Stage 1: BP between 140 and 159 (systolic) and 90 and 99 mmHg (diastolic); Stages 2 and 
3: BP ≥160/100 mmHg
Table 5 – Analysis of the SBT performance in WCH identification.
Criterion 1 Criterion 2 
Sensitivity 0.54 (0.36 to 0.71) 0.75 (0.57 to 0.87) 
Specificity 0.78 (0.67 to 0.87) 0.81 (0.70 to 0.89) 
PPV 0.52 (0.34 to 0.69) 0.64 (0.47 to 0.78) 
NPV 0.79 (0.68 to 0.88) 0.88 (0.78 to 0.94) 
PLR 2.5 (1.4 to 4.4) 4.0 (2.3 to 7.0) 
NLR 0.6 (0.40 to 0.90) 0.3 (0.16 to 0.59) 
Kappa Test -0.12 (-0.67 to 0.42) 0.42 (0.02 to 0.86) 
SBT - slow breathing test; WCH - white coat hypertension; criterion 
1: decrease in DBP ≥10% after SBT in at least one of the two visits; 
criterion 2: decrease in BP to < 140/90 mm Hg after SBT in at least 
one of the two visits; PPV - positive predictive value; NVP - negative 
predictive value ;PLR - positive likelihood ratio; NLR: negative likelihood 
ratio.
Graph 1 - Comparison of the performance between criterion 1 and criterion 
2; Sens - Sensitivity; Spc - specificity; PPV - positive predictive value; NPV 
- negative predictive value; Criterion 1: decrease in DBP ≥10% after SBT in 
at least one of the two visits;  Criterion 2: decrease in BP to < 140/90 mm Hg 
after SBT in at least one of the two visits;
The present study suggests that the SBT is more effective 
as proposed here than as proposed by Yoshihara et al13. 
These authors reported better differentiation of the test 
effect between the groups when using the percentage 
decrease in diastolic BP on the first of three visits. In our 
study, the test was performed on two visits after triage, when 
the habituation effect that occurs along the repetition of 
the visits may enhance the effect of slow breathing. This is 
a probable cause of the more intense decrease in post-test 
systolic BP on the second visit in comparison to the first, 
for both WCH and HT groups (Table 1). 
Additionally, the criterion of BP normalization is easily 
interpreted by the physician. These criteria were derived 
from the literature (criterion 1)13 and from our own 
observation (criterion 2).
We also evaluated two other alternative criteria: decrease 
in diastolic BP ≥5% and decrease in systolic BP ≥10%. For 
these criteria, we obtained sensitivity of 68% and 54% and 
specificity of 36% and 55% for these cutoffs, respectively. 
The prevalence of WCH is inversely proportional to the 
severity of hypertension in the office21. The responses to the 
SBT according to the stages of hypertension (Tables 4 and 5) 
indicated that the results using the criterion 2 (Table 5) respected 
the same determinants for the ABPM in the diagnosis of WCH: 
the lower the stage of clinical hypertension, the higher the chance 
of positivity for WCH when applying the SBT.
The larger number of women in our series reflects the 
frequency of users in this Service (7 women: 3 men). This fact is 
not surprising, as it is known in Brazil that women seek health 
services more often than men22. It is very important to attain the 
diagnosis of WCH in women, as they are more susceptible to this 
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